The kidney can mediate its own repair through proliferation of resident immune system cells.

Structural studies reveal a new framework for understanding a central player in DNA processing.

HDL cholesterol is impaired in patients with chronic kidney disease – and may increase their cardiovascular disease risk.

Understanding how the main receptor for light interacts with other signaling molecules may inform new pharmaceutical development.

It may be possible to fight hospital-acquired pathogens like Acinetobacter baumannii by targeting the bacterium’s need for the nutrient metal zinc.

Blocking a serotonin receptor may provide a novel therapy for heart valve disease.

Combining another drug with platinum-based chemotherapies may be more effective against ovarian cancer.